PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 46 filers reported holding PROQR THRAPEUTICS N V in Q2 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $617,000 | +57.4% | 93,400 | 0.0% | 0.00% | – |
Q4 2020 | $392,000 | -14.2% | 93,400 | -2.1% | 0.00% | – |
Q3 2020 | $457,000 | -9.5% | 95,400 | +14.8% | 0.00% | – |
Q2 2020 | $505,000 | +85.0% | 83,100 | +66.9% | 0.00% | – |
Q1 2020 | $273,000 | -44.7% | 49,800 | 0.0% | 0.00% | – |
Q4 2019 | $494,000 | +425.5% | 49,800 | +382.4% | 0.00% | – |
Q2 2019 | $94,000 | -78.5% | 10,324 | -67.2% | 0.00% | -100.0% |
Q1 2019 | $437,000 | -33.8% | 31,497 | -24.7% | 0.00% | 0.0% |
Q4 2018 | $660,000 | – | 41,840 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |